• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2014-2017 年意大利致病例脑膜炎奈瑟氏菌 B 分离株中脑膜炎 B 疫苗抗原 FHbp 变体。

Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014-2017.

机构信息

Department Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Scientific Department, Army Medical Center, Rome, Italy.

出版信息

PLoS One. 2020 Nov 11;15(11):e0241793. doi: 10.1371/journal.pone.0241793. eCollection 2020.

DOI:10.1371/journal.pone.0241793
PMID:33176334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7657669/
Abstract

BACKGROUND

Typing of Neisseria meningitidis isolates is crucial for the surveillance of invasive meningococcal disease (IMD). We performed a molecular epidemiology study of N. meningitidis serogroup B (MenB) causing IMD in Italy between 2014 and 2017 to describe circulating strains belonging to this serogroup, with particular regards to the two factor H-binding protein (FHbp) subfamilies present in the bivalent MenB vaccine.

MATERIALS AND METHODS

A total of 109 culture positive and 46 culture negative MenB samples were collected within the National Surveillance System (NSS) of IMD in Italy and molecularly analyzed by conventional methods.

RESULTS

Overall, 71 MenB samples showed the FHbp subfamily A and 83 the subfamily B. The subfamily variants were differently distributed by age. The most frequent variants, A05 and B231, were associated with cc213 and cc162, respectively. All MenB with the FHbp A05 variant displayed the PorA P1.22,14 and 85.7% of them the FetA F5-5. The majority of MenB with the FHbp B231 variant showed the PorA P1.22,14 (65.4%) and 84.6%, the FetA F3-6.

CONCLUSION

MenB circulating in Italy were characterized by a remarkable association between clonal complex and FHbp variants, although a high degree of genetic diversity observed over time. A dynamic trend in clonal complexes distribution within MenB was detected. Our results stress the importance of continued meningococcal molecular surveillance to evaluate the potential vaccine coverage of the available MenB vaccines.

摘要

背景

脑膜炎奈瑟菌分离株的分型对于侵袭性脑膜炎球菌病(IMD)的监测至关重要。我们对 2014 年至 2017 年期间意大利引起 IMD 的脑膜炎奈瑟菌 B 群(MenB)进行了分子流行病学研究,以描述属于该血清群的循环菌株,特别关注二价 MenB 疫苗中存在的两种因子 H 结合蛋白(FHbp)亚家族。

材料和方法

在意大利 IMD 国家监测系统(NSS)中总共收集了 109 份培养阳性和 46 份培养阴性的 MenB 样本,并通过常规方法进行了分子分析。

结果

总体而言,71 份 MenB 样本显示 FHbp 亚家族 A,83 份样本显示 FHbp 亚家族 B。亚家族变异按年龄分布不同。最常见的变异 A05 和 B231 分别与 cc213 和 cc162 相关。所有带有 FHbp A05 变异的 MenB 均显示 PorA P1.22,14,并且 85.7%的 MenB 带有 FetA F5-5。带有 FHbp B231 变异的大多数 MenB 显示 PorA P1.22,14(65.4%)和 84.6%,带有 FetA F3-6。

结论

意大利流行的 MenB 具有明显的克隆复合体与 FHbp 变异相关的特征,尽管随着时间的推移观察到高度的遗传多样性。在 MenB 内克隆复合体分布的动态趋势被检测到。我们的研究结果强调了持续进行脑膜炎球菌分子监测的重要性,以评估现有 MenB 疫苗的潜在疫苗覆盖率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff2c/7657669/0b7400889f53/pone.0241793.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff2c/7657669/8305c97615f9/pone.0241793.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff2c/7657669/fd3d1e18ee83/pone.0241793.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff2c/7657669/da1a3c93ff14/pone.0241793.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff2c/7657669/0b7400889f53/pone.0241793.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff2c/7657669/8305c97615f9/pone.0241793.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff2c/7657669/fd3d1e18ee83/pone.0241793.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff2c/7657669/da1a3c93ff14/pone.0241793.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff2c/7657669/0b7400889f53/pone.0241793.g004.jpg

相似文献

1
Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014-2017.2014-2017 年意大利致病例脑膜炎奈瑟氏菌 B 分离株中脑膜炎 B 疫苗抗原 FHbp 变体。
PLoS One. 2020 Nov 11;15(11):e0241793. doi: 10.1371/journal.pone.0241793. eCollection 2020.
2
Molecular characterization of invasive serogroup B Neisseria meningitidis isolates from Spain during 2015-2018: Evolution of the vaccine antigen factor H binding protein (FHbp).2015-2018 年期间西班牙侵袭性 B 群脑膜炎奈瑟菌分离株的分子特征:疫苗抗原因子 H 结合蛋白(FHbp)的演变。
J Infect. 2021 Apr;82(4):37-44. doi: 10.1016/j.jinf.2021.01.030. Epub 2021 Feb 18.
3
Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 isolates causing invasive meningococcal disease in Argentina in 2010-2014.2010-2014 年阿根廷 284 株侵袭性脑膜炎奈瑟菌分离株的遗传特征及 4CMenB 疫苗株的估计覆盖率。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2378537. doi: 10.1080/21645515.2024.2378537. Epub 2024 Jul 22.
4
Estimated strain coverage of serogroup B meningococcal vaccines: A retrospective study for disease and carrier strains in Greece (2010-2017).估计 B 群脑膜炎球菌疫苗的菌株覆盖率:希腊疾病和带菌菌株的回顾性研究(2010-2017 年)。
Vaccine. 2021 Mar 12;39(11):1621-1630. doi: 10.1016/j.vaccine.2021.01.073. Epub 2021 Feb 15.
5
Molecular characterization of invasive isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage.2009-2019 年在立陶宛采集的侵袭性分离株的分子特征及 B 群脑膜炎球菌疫苗 4CMenB 和 MenB-Fhbp 覆盖率的评估。
Front Cell Infect Microbiol. 2023 Feb 15;13:1136211. doi: 10.3389/fcimb.2023.1136211. eCollection 2023.
6
Factor H binding protein (FHbp): An evaluation of genotypic diversity across serogroups.因子 H 结合蛋白(FHbp):对各血清群的基因多样性评估。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2409502. doi: 10.1080/21645515.2024.2409502. Epub 2024 Oct 10.
7
Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland.侵袭性 B 群脑膜炎奈瑟菌分离株的基因组特征及芬兰 4CMenB 疫苗覆盖率的估计。
mSphere. 2020 Sep 16;5(5):e00376-20. doi: 10.1128/mSphere.00376-20.
8
A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccine.一种用于非洲的脑膜炎球菌NOMV-FHbp疫苗,与一种已获许可的B群疫苗相比,能引发针对B群和非B群菌株的更广泛的血清杀菌抗体反应。
Vaccine. 2016 Jan 27;34(5):643-649. doi: 10.1016/j.vaccine.2015.12.034. Epub 2015 Dec 20.
9
Broad vaccine protection against Neisseria meningitidis using factor H binding protein.利用补体因子 H 结合蛋白实现对脑膜炎奈瑟菌的广泛疫苗保护
Vaccine. 2020 Nov 17;38(49):7716-7727. doi: 10.1016/j.vaccine.2020.08.031. Epub 2020 Aug 30.
10
Phenotypic and genotypic characterization of meningococcal isolates in Tunis, Tunisia: High diversity and impact on vaccination strategies.突尼斯突尼斯脑膜炎奈瑟菌分离株的表型和基因型特征:高度多样性及其对疫苗接种策略的影响。
Int J Infect Dis. 2020 Feb;91:73-78. doi: 10.1016/j.ijid.2019.11.013. Epub 2019 Nov 20.

引用本文的文献

1
Invasive Meningococcal Disease and Meningococcal Serogroup B Vaccination in Adults and Their Offspring: Knowledge, Attitudes, and Practices in Italy (2019).成人及其后代中的侵袭性脑膜炎球菌病和B群脑膜炎球菌疫苗接种:意大利的知识、态度和实践(2019年)
Vaccines (Basel). 2023 Feb 22;11(3):508. doi: 10.3390/vaccines11030508.
2
FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014-2017.2014-2017 年意大利 B 群脑膜炎奈瑟菌 FHbp 变异体:进化和选择压力
PLoS One. 2023 Feb 16;18(2):e0277976. doi: 10.1371/journal.pone.0277976. eCollection 2023.
3
Self-assembling protein nanoparticles and virus like particles correctly display β-barrel from meningococcal factor H-binding protein through genetic fusion.

本文引用的文献

1
Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp).加拿大脑膜炎奈瑟菌 B 分离株对脑膜炎奈瑟菌 B 疫苗(MenB-FHbp)的估计易感性。
Vaccine. 2020 Feb 18;38(8):2026-2033. doi: 10.1016/j.vaccine.2019.12.051. Epub 2020 Jan 23.
2
Genomic surveillance of invasive meningococcal disease in the Czech Republic, 2015-2017.2015-2017 年捷克侵袭性脑膜炎奈瑟菌病的基因组监测。
PLoS One. 2019 Jul 11;14(7):e0219477. doi: 10.1371/journal.pone.0219477. eCollection 2019.
3
B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of .
自组装蛋白纳米颗粒和类病毒颗粒通过基因融合正确展示脑膜炎奈瑟菌因子 H 结合蛋白的β-桶状结构。
PLoS One. 2022 Sep 16;17(9):e0273322. doi: 10.1371/journal.pone.0273322. eCollection 2022.
B 部分为离校生议定书:一项观察性重复横断面研究,旨在评估脑膜炎奈瑟菌 B 群(4CMenB)疫苗计划对. 带菌情况的影响。
BMJ Open. 2019 May 6;9(5):e027233. doi: 10.1136/bmjopen-2018-027233.
4
Concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults: a review of available evidence.脑膜炎球菌疫苗与其他疫苗在青少年和成人中的同时接种:现有证据的综述。
Hum Vaccin Immunother. 2019;15(9):2205-2216. doi: 10.1080/21645515.2019.1581542. Epub 2019 Apr 19.
5
Cocirculation of Hajj and non-Hajj strains among serogroup W meningococci in Italy, 2000 to 2016.2000 年至 2016 年期间,意大利血清群 W 脑膜炎奈瑟菌中朝觐和非朝觐菌株的共同循环。
Euro Surveill. 2019 Jan;24(4). doi: 10.2807/1560-7917.ES.2019.24.4.1800183.
6
An outbreak of severe invasive meningococcal disease due to a capsular switched Neisseria meningitidis hypervirulent strain B:cc11.由于荚膜转换的高毒力脑膜炎奈瑟菌 B:cc11 引起的严重侵袭性脑膜炎球菌病爆发。
Clin Microbiol Infect. 2019 Jan;25(1):111.e1-111.e4. doi: 10.1016/j.cmi.2018.07.014. Epub 2018 Jul 21.
7
Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine.预测脑膜炎奈瑟菌 B 群分离株对新型预防疫苗 bivalent rLP2086 诱导的杀菌抗体的敏感性。
mBio. 2018 Mar 13;9(2):e00036-18. doi: 10.1128/mBio.00036-18.
8
MenB-FHbp Meningococcal Group B Vaccine (Trumenba): A Review in Active Immunization in Individuals Aged ≥ 10 Years.B 型脑膜炎球菌结合疫苗(特鲁姆巴)在 10 岁及以上人群中的主动免疫作用:一项综述。
Drugs. 2018 Feb;78(2):257-268. doi: 10.1007/s40265-018-0869-7.
9
Prevalence of factor H Binding Protein sub-variants among Neisseria meningitidis in China.中国脑膜炎奈瑟菌中H因子结合蛋白亚变体的流行情况。
Vaccine. 2017 Apr 25;35(18):2343-2350. doi: 10.1016/j.vaccine.2017.03.057. Epub 2017 Mar 25.
10
The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection.全球脑膜炎球菌倡议:全球流行病学、疫苗对脑膜炎球菌病的影响以及群体保护的重要性。
Expert Rev Vaccines. 2017 Apr;16(4):313-328. doi: 10.1080/14760584.2017.1258308. Epub 2016 Nov 22.